Cologne, Germany / Basel, Switzerland, 14 March 2016 – Lonza has launched PowerCHO Advance™ Media, the latest addition to the company’s range of specialized, chemically defined, serum-free media for culturing Chinese Hamster Ovary (CHO) cells. The new PowerCHO Advance™ Media line offers easy filterability, improved cell-growth promotion and high protein titers. In addition to being hydrolysate-free, serum-free and of non-animal origin, the PowerCHO Advance™ Media offerings are now further enhanced to better support high-density CHO cells in suspension. For therapeutic bioprocessing applications, this medium also facilitates both downstream purification and regulatory compliance.
PowerCHO Advance™ Media allow for easy scalability, so users do not need to change to a new medium as they progress from research projects through to large-scale production. The medium is also fully chemically defined, which eases the regulatory process when transitioning from research into clinical trials and U.S. Food and Drug Administration (FDA) submission. The balanced formulation allows users to maintain high viability (greater than 90%), even at high cell densities while it has also been shown to provide higher protein titer when compared with leading media formulations on the market.
Amber Jones, Lonza’s Product Manager Media, explains: “The addition of PowerCHO Advance™ Media offerings demonstrates Lonza’s commitment to providing scientists efficient, reliable, cost-effective cell culture media that can be used throughout the research process and beyond.” For more product details, please visit www.lonza.com/PowerCHO
About Lonza
Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. We harness science and technology to create products that support safer and healthier living and that enhance the overall quality of life.
Not only are we a custom manufacturer and developer, Lonza also offers services and products ranging from active pharmaceutical ingredients and stem-cell therapies to drinking water sanitizers, from the vitamin B compounds and organic personal care ingredients to agricultural products, and from industrial preservatives to microbial control solutions that combat dangerous viruses, bacteria and other pathogens.
Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 40 major manufacturing and R&D facilities and approximately 9,800 full-time employees worldwide. The company generated sales of CHF 3.8 billion in 2015 and is organized into two market-focused segments: Pharma&Biotech and Specialty Ingredients. Further information can be found at www.lonza.com.
Lonza Contact Information
Lonza Cologne GmbH
Manager Marketing Communications
Petra Haberkamm
Tel +49 221 991990
Fax +49 221 99199498
marcom.lbs@lonza.com
Lonza Group Ltd
Head Corporate Communications
Dominik Werner
Tel +41 61 316 8798
Fax +41 61 316 9540
dominik.werner@lonza.com
Lonza Group Ltd
Head External Communications
Constance Ward
Tel +41 61 316 8840
Fax +41 61 316 9840
constance.ward@lonza.com
